U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 52 results

Status:
US Approved Rx (2024)
First approved in 2017

Class (Stereo):
CHEMICAL (ABSOLUTE)



AR-13503 is an active metabolite of Netarsudil
Status:
US Approved Rx (2019)
First approved in 2012

Class (Stereo):
CHEMICAL (ABSOLUTE)



Tafluprost acid is a prostanoid selective FP receptor agonist that is believed to reduce the intraocular pressure (IOP) by increasing the outflow of aqueous humor. Studies in animals and humans suggest that the main mechanism of action is increased u...
Status:
US Approved Rx (2010)
First approved in 2001

Class (Stereo):
CHEMICAL (ABSOLUTE)



Bimatoprost (marketed in the US, Canada and Europe by Allergan, under the trade name Lumigan) ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is...
Status:
US Approved Rx (2013)
First approved in 1998

Class (Stereo):
CHEMICAL (ABSOLUTE)



Brinzolamide reduces the amount of fluid in the eye, which decreases pressure inside the eye. Brinzolamide is a carbonic anhydrase inhibitor that is FDA approved for the treatment of elevated intraocular pressure in patients with ocular hypertension ...
Status:
US Approved Rx (2022)
First approved in 1996

Class (Stereo):
CHEMICAL (ACHIRAL)



Brimonidine reduces the amount of fluid in the eye, which decreases pressure inside the eye. Brimonidine ophthalmic (for the eyes) is used to treat open-angle glaucoma or ocular hypertension (high pressure inside the eye). Brimonidine is an alpha adr...
Status:
US Approved Rx (2011)
First approved in 1995

Class (Stereo):
CHEMICAL (ABSOLUTE)



Latanoprost (free acid) is a metabolite of latanoprost which has been approved for use as an ocular hypotensive drug. Latanoprost is an isopropyl ester prodrug which is converted to the Latanoprost-acid by endogenous esterase enzymes. The free acid i...
Status:
US Approved Rx (2008)
First approved in 1994

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dorzolamide is a sulfonamide and a highly specific carbonic anhydrase II (CA-II) inhibitor, which is the main CA isoenzyme involved in aqueous humor secretion. Dorzolamide is marketed under the trade name Trusopt, indicated in the treatment of elevat...
Status:
US Approved Rx (1987)
First approved in 1987

Class (Stereo):
CHEMICAL (ACHIRAL)



Apraclonidine (IOPIDINE) is an α2-adrenergic receptor agonist and a weak α1-adrenergic receptor agonist. It is used for the prevention and treatment of postsurgical intraocular pressure elevation. The following adverse events, occurring in less than ...
Status:
US Approved Rx (1985)
First approved in 1985

Class (Stereo):
CHEMICAL (ABSOLUTE)



Levobunolol is a non-cardioselective beta-adrenoceptor blocking agent, equipotent at both beta1 and beta2 adrenergic receptors. Levobunolol is greater than 60 times more potent than its dextro isomer in its beta-blocking activity, yet equipotent in i...
Status:
US Approved Rx (2009)
First approved in 1985

Class (Stereo):
CHEMICAL (RACEMIC)



Betaxolol or SL 75212, (± )-1-(isopropylamino)-3-(p-(cyclopropylmethoxyethyl-phenoxy)2-propranol, is a potent cardioselective beta1-adrenoceptor antagonist devoid of intrinsic sympathomimetic activity with very weak local anaesthetic properties. Oral...